Akoya Biosciences IncNASDAQ:AKYA
- LAST PRICE3.8000
- TODAY'S CHANGE (%)-0.0200 (-0.5236%)
- Bid / Lots3.7500/ 3
- Ask / Lots5.9700/ 15
- Open / Previous Close3.8000 / 3.8200
- Day Range
- 52 Week Range
- Volume93,172
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | AKYA |
|---|---|---|
| 09:32 ET | 1701 | 3.8 |
| 09:59 ET | 8900 | 3.84 |
| 10:01 ET | 9802 | 3.81 |
| 10:03 ET | 100 | 3.8 |
| 10:08 ET | 100 | 3.81 |
| 10:12 ET | 400 | 3.81 |
| 10:14 ET | 740 | 3.81 |
| 10:24 ET | 100 | 3.79 |
| 10:32 ET | 600 | 3.79 |
| 10:39 ET | 200 | 3.77 |
| 10:46 ET | 11456 | 3.77 |
| 10:48 ET | 100 | 3.76 |
| 10:50 ET | 100 | 3.76 |
| 10:51 ET | 300 | 3.78 |
| 10:53 ET | 100 | 3.76 |
| 11:00 ET | 225 | 3.78 |
| 11:02 ET | 700 | 3.78 |
| 11:09 ET | 100 | 3.795 |
| 11:18 ET | 100 | 3.8 |
| 11:26 ET | 200 | 3.77 |
| 11:29 ET | 100 | 3.76 |
| 11:33 ET | 100 | 3.76 |
| 11:36 ET | 100 | 3.79 |
| 11:38 ET | 100 | 3.75 |
| 11:40 ET | 117 | 3.75 |
| 11:42 ET | 100 | 3.76 |
| 11:44 ET | 100 | 3.75 |
| 11:45 ET | 200 | 3.77 |
| 11:47 ET | 100 | 3.75 |
| 11:49 ET | 100 | 3.75 |
| 11:54 ET | 200 | 3.76 |
| 11:56 ET | 300 | 3.77 |
| 11:58 ET | 1100 | 3.77 |
| 12:03 ET | 300 | 3.79 |
| 12:07 ET | 200 | 3.78 |
| 12:20 ET | 100 | 3.81 |
| 12:38 ET | 100 | 3.78 |
| 12:39 ET | 400 | 3.786 |
| 12:50 ET | 300 | 3.77 |
| 12:52 ET | 100 | 3.77 |
| 12:56 ET | 1700 | 3.8 |
| 01:01 ET | 100 | 3.8 |
| 01:03 ET | 200 | 3.81 |
| 01:08 ET | 100 | 3.82 |
| 01:15 ET | 141 | 3.8137 |
| 01:17 ET | 100 | 3.82 |
| 01:21 ET | 100 | 3.83 |
| 01:24 ET | 135 | 3.84 |
| 01:32 ET | 1000 | 3.825 |
| 01:37 ET | 2100 | 3.81 |
| 01:42 ET | 1496 | 3.82 |
| 01:44 ET | 1300 | 3.81 |
| 01:46 ET | 871 | 3.81 |
| 01:48 ET | 606 | 3.82 |
| 01:50 ET | 100 | 3.82 |
| 01:55 ET | 2293 | 3.81 |
| 01:57 ET | 200 | 3.81 |
| 02:00 ET | 136 | 3.81 |
| 02:04 ET | 200 | 3.8 |
| 02:06 ET | 300 | 3.8 |
| 02:09 ET | 100 | 3.8 |
| 02:11 ET | 800 | 3.8 |
| 02:13 ET | 1589 | 3.8 |
| 02:15 ET | 200 | 3.805 |
| 02:24 ET | 500 | 3.8 |
| 02:26 ET | 100 | 3.82 |
| 02:38 ET | 116 | 3.82 |
| 02:40 ET | 100 | 3.81 |
| 02:42 ET | 300 | 3.81 |
| 02:45 ET | 100 | 3.81 |
| 02:49 ET | 100 | 3.81 |
| 02:51 ET | 200 | 3.815 |
| 02:54 ET | 100 | 3.81 |
| 02:56 ET | 100 | 3.81 |
| 02:58 ET | 100 | 3.81 |
| 03:02 ET | 1400 | 3.82 |
| 03:03 ET | 234 | 3.82 |
| 03:05 ET | 100 | 3.825 |
| 03:09 ET | 300 | 3.82 |
| 03:14 ET | 1428 | 3.83 |
| 03:21 ET | 1000 | 3.83 |
| 03:27 ET | 100 | 3.84 |
| 03:30 ET | 200 | 3.82 |
| 03:32 ET | 2989 | 3.81 |
| 03:36 ET | 400 | 3.8 |
| 03:38 ET | 320 | 3.81 |
| 03:39 ET | 200 | 3.81 |
| 03:41 ET | 200 | 3.83 |
| 03:43 ET | 400 | 3.81 |
| 03:45 ET | 750 | 3.8 |
| 03:48 ET | 200 | 3.8 |
| 03:50 ET | 400 | 3.8 |
| 03:52 ET | 300 | 3.8 |
| 03:54 ET | 100 | 3.805 |
| 03:56 ET | 1165 | 3.81 |
| 03:57 ET | 1206 | 3.8 |
| 03:59 ET | 10659 | 3.8 |
Apr 22, 2024
Akoya to Report First Quarter 2024 Financial Results on May 13th, 2024, from 4:05PM ET on Monday Apr 22, 2024 by Dow Jones
4:05PM ET on Monday Apr 22, 2024 by Dow Jones
Apr 5, 2024
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Akoya Biosciences Inc | 187.7M | -2.6x | --- |
Fonar Corp | 113.1M | 9.3x | -15.67% |
Harvard Bioscience Inc | 154.6M | -45.1x | --- |
Xylo Technologies Ltd | 3.1M | -0.2x | --- |
Butterfly Network Inc | 146.7M | -1.2x | --- |
ViewRay Inc | 25.3K | 0.0x | --- |
Company Information
Akoya Biosciences, Inc. is a life sciences technology company delivering spatial biology solutions focused on transforming discovery, clinical research, and diagnostics. It offers single-cell imaging solutions that allow researchers to phenotype cells with spatial context and visualize how they organize and interact to influence disease progression and response to therapy. It offers a full continuum of spatial phenotyping solutions to serve the diverse needs of researchers across discovery, translational and clinical research: PhenoCode Panels and PhenoCycler, PhenoImager Fusion and PhenoImager HT Instruments. Its PhenoCycler platform provides ultra-high parameter biomarker discovery, with the ability to analyze high-plex single-cell resolution across the entire tissue sample. Its PhenoImager platform enables researchers to visualize, analyze, quantify and phenotype cells in situ, in fresh frozen or formalin-fixed paraffin-embedded (FFPE) tissue sections, and tissue microarrays (TMAs).
Contact Information
- Headquarters
- 100 Campus Drive, 6Th FloorMARLBOROUGH, MA, United States 01762
- Phone
- 415-765-6980
- Fax
- ---
Executives
- Chairman of the Board
- Robert Shepler
- President, Chief Executive Officer, Director
- Brian McKelligon
- Chief Financial Officer
- Johnny Ek
- Chief Operating Officer
- Frederic Pla
- General Counsel
- Jennifer Kamocsay
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $187.7M |
|---|---|
Revenue (TTM) | $96.6M |
Shares Outstanding | 49.1M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | --- |
EPS | $-1.48 |
Book Value | $1.09 |
P/E Ratio | -2.6x |
Price/Sales (TTM) | 1.9 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -59.68% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
